122 related articles for article (PubMed ID: 37837672)
1. Design, synthesis, and biological evaluation of quinoline-piperazine/pyrrolidine derivatives as possible antileishmanial agents.
Katiyar S; Ramalingam K; Kumar A; Ansari A; Bisen AC; Mishra G; Sanap SN; Bhatta RS; Purkait B; Goyal N; Sashidhara KV
Eur J Med Chem; 2023 Dec; 261():115863. PubMed ID: 37837672
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents.
Upadhyay A; Kushwaha P; Gupta S; Dodda RP; Ramalingam K; Kant R; Goyal N; Sashidhara KV
Eur J Med Chem; 2018 Jun; 154():172-181. PubMed ID: 29793211
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
[TBL] [Abstract][Full Text] [Related]
4. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
[TBL] [Abstract][Full Text] [Related]
5. Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani.
Yousuf M; Mukherjee D; Dey S; Pal C; Adhikari S
Eur J Med Chem; 2016 Nov; 124():468-479. PubMed ID: 27598235
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of N-acyl and dimeric N-Arylpiperazine derivatives as potential antileishmanial agents.
Ansari SB; Kamboj S; Ramalingam K; Meena R; Lal J; Kant R; Shukla SK; Goyal N; Reddy DN
Bioorg Chem; 2023 Aug; 137():106593. PubMed ID: 37186964
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents.
Gopinath VS; Pinjari J; Dere RT; Verma A; Vishwakarma P; Shivahare R; Moger M; Kumar Goud PS; Ramanathan V; Bose P; Rao MV; Gupta S; Puri SK; Launay D; Martin D
Eur J Med Chem; 2013 Nov; 69():527-36. PubMed ID: 24095747
[TBL] [Abstract][Full Text] [Related]
8. Novel hybrid selenosulfonamides as potent antileishmanial agents.
Baquedano Y; Moreno E; Espuelas S; Nguewa P; Font M; Gutierrez KJ; Jiménez-Ruiz A; Palop JA; Sanmartín C
Eur J Med Chem; 2014 Mar; 74():116-23. PubMed ID: 24448421
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel halogen rich salicylanilides as potential antileishmanial agents.
Lal J; Ramalingam K; Meena R; Ansari SB; Saxena D; Chopra S; Goyal N; Reddy DN
Eur J Med Chem; 2023 Jan; 246():114996. PubMed ID: 36565533
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a new antileishmanial hit in 8-nitroquinoline series.
Paloque L; Verhaeghe P; Casanova M; Castera-Ducros C; Dumètre A; Mbatchi L; Hutter S; Kraiem-M'rabet M; Laget M; Remusat V; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2012 Aug; 54():75-86. PubMed ID: 22608675
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Antileishmanial Activity of 1,2,4,5-Tetraoxanes against
Cabral LIL; Pomel S; Cojean S; Amado PSM; Loiseau PM; Cristiano MLS
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979089
[TBL] [Abstract][Full Text] [Related]
12. In vitro 4-Aryloxy-7-chloroquinoline derivatives are effective in mono- and combined therapy against Leishmania donovani and induce mitocondrial membrane potential disruption.
Valdivieso E; Mejías F; Torrealba C; Benaim G; Kouznetsov VV; Sojo F; Rojas-Ruiz FA; Arvelo F; Dagger F
Acta Trop; 2018 Jul; 183():36-42. PubMed ID: 29604246
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Biological Evaluation, Structure-Activity Relationship, and Mechanism of Action Studies of Quinoline-Metronidazole Derivatives Against Experimental Visceral Leishmaniasis.
Upadhyay A; Chandrakar P; Gupta S; Parmar N; Singh SK; Rashid M; Kushwaha P; Wahajuddin M; Sashidhara KV; Kar S
J Med Chem; 2019 Jun; 62(11):5655-5671. PubMed ID: 31124675
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives.
Dea-Ayuela MA; Bilbao-Ramos P; Bolás-Fernández F; González-Cardenete MA
Eur J Med Chem; 2016 Oct; 121():445-450. PubMed ID: 27318121
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, in vitro and in vivo biological evaluation of pyranone-piperazine analogs as potent antileishmanial agents.
Mishra S; Parmar N; Chandrakar P; Sharma CP; Parveen S; Vats RP; Seth A; Goel A; Kar S
Eur J Med Chem; 2021 Oct; 221():113516. PubMed ID: 33992928
[TBL] [Abstract][Full Text] [Related]
16. Antileishmanial activity of cryptolepine analogues and apoptotic effects of 2,7-dibromocryptolepine against Leishmania donovani promastigotes.
Hazra S; Ghosh S; Debnath S; Seville S; Prajapati VK; Wright CW; Sundar S; Hazra B
Parasitol Res; 2012 Jul; 111(1):195-203. PubMed ID: 22297912
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of leishmaniasis. Part IX: synthesis and bioevaluation of aryl substituted ketene dithioacetals as antileishmanial agents.
Kumar S; Tiwari A; Suryawanshi SN; Mittal M; Vishwakarma P; Gupta S
Bioorg Med Chem Lett; 2012 Nov; 22(21):6728-30. PubMed ID: 23031588
[TBL] [Abstract][Full Text] [Related]
19. New antileishmanial quinoline linked isatin derivatives targeting DHFR-TS and PTR1: Design, synthesis, and molecular modeling studies.
Sabt A; Eldehna WM; Ibrahim TM; Bekhit AA; Batran RZ
Eur J Med Chem; 2023 Jan; 246():114959. PubMed ID: 36493614
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of ferrocenylquinoline as a potential antileishmanial agent.
Yousuf M; Mukherjee D; Pal A; Dey S; Mandal S; Pal C; Adhikari S
ChemMedChem; 2015 Mar; 10(3):546-54. PubMed ID: 25619822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
